SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (294)2/17/2000 3:31:00 PM
From: Cooters  Respond to of 359
 
Aurora Biosciences Rated New `Strong Buy' at Thomas Weisel

--From AtHome News-- Cooters

Princeton, New Jersey, Feb. 17 (Bloomberg Data) -- Aurora Biosciences Corp. (ABSC US) was rated new ``strong buy' in new coverage by analyst Scott R Greenstone at Thomas Weisel Partners. The price target is $95.



To: tuck who wrote (294)2/28/2000 3:37:00 PM
From: Vector1  Read Replies (1) | Respond to of 359
 
Tuck,
I am out. It sure has been a fun ride to triple digits. The valuation however at this point is difficult to justify.
V1